CE-certified AI-powered benchtop platform automating 3D tissue selection and transfer for scalable drug discovery
Keep browsing
Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.
Management of acute and chronic symptoms of chemotherapy-induced sensory peripheral neuropathy.
Alzheimer’s disease